Publication details

Profil aktivace receptorových tyrozinkináz a mitogenem aktivovaných proteinkináz v terapii Maffucciho syndromu

Investor logo
Title in English Profile of activation of tyrosine kinases and MAP kinases in therapy of Maffucci syndrome
Authors

MELICHÁRKOVÁ Kristýna NERADIL Jakub MÚDRY Peter ZITTERBART Karel OBERMANNOVÁ R. SKOTÁKOVÁ Jarmila VESELSKÁ Renata ŠTĚRBA Jaroslav

Year of publication 2015
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.14735/amko20152S47
Field Oncology and hematology
Keywords enchondromatosis; hemangioma; receptor protein-tyrosine kinases; MAP kinases signaling system; individualized medicine; Maff ucci syndrome
Description Background: Maff ucci syndrome is a rare congenital non-hereditary disease characterized by multiple hemangiomas and enchondromas, which may progress into malignancy. The causal therapy does not exist, and therapy is aimed at complications. The determination of appropriate therapy is complicated, and a multidisciplinary approach is often essential. Case: Authors are presenting the case of a 20-year- old patient with Maff ucci syndrome. During her life, multiple enchondromas and progressing hemangiomas have been revealed and they have caused many complications, such as limited movement, growth failure, pain, fl uidothorax and ascites. A profi le of phosphorylation of selected tyrosine kinases and MAP kinases from progressing hemangioma was performed and with consideration of the result, it led to change of treatment strategy with encouraging clinical response lasting for six months.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info